A detailed history of Marietta Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Marietta Wealth Management, LLC holds 7,712 shares of REGN stock, worth $8.06 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
7,712
Previous 7,853 1.8%
Holding current value
$8.06 Million
Previous $6.9 Million 7.61%
% of portfolio
1.26%
Previous 1.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$902.69 - $993.35 $127,279 - $140,062
-141 Reduced 1.8%
7,712 $7.42 Million
Q4 2023

Jan 30, 2024

BUY
$775.18 - $881.7 $15,503 - $17,634
20 Added 0.26%
7,853 $6.9 Million
Q3 2023

Oct 30, 2023

SELL
$692.45 - $844.37 $143,337 - $174,784
-207 Reduced 2.57%
7,833 $6.45 Million
Q2 2023

Jul 18, 2023

BUY
$700.03 - $830.35 $84,003 - $99,642
120 Added 1.52%
8,040 $5.78 Million
Q1 2023

Apr 27, 2023

SELL
$680.49 - $826.97 $195,981 - $238,167
-288 Reduced 3.51%
7,920 $6.51 Million
Q4 2022

Jan 30, 2023

SELL
$705.89 - $766.39 $235,061 - $255,207
-333 Reduced 3.9%
8,208 $5.92 Million
Q3 2022

Oct 20, 2022

SELL
$573.97 - $724.32 $210,073 - $265,101
-366 Reduced 4.11%
8,541 $5.88 Million
Q2 2022

Aug 08, 2022

BUY
$548.35 - $738.84 $59,221 - $79,794
108 Added 1.23%
8,907 $5.27 Million
Q1 2022

Apr 12, 2022

BUY
$595.12 - $698.43 $368,379 - $432,328
619 Added 7.57%
8,799 $6.15 Million
Q4 2021

Jan 28, 2022

BUY
$543.48 - $670.97 $541,306 - $668,286
996 Added 13.86%
8,180 $5.17 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $1.39 Million - $1.64 Million
2,415 Added 50.64%
7,184 $4.35 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $125,292 - $148,013
265 Added 5.88%
4,769 $2.66 Million
Q1 2021

May 06, 2021

BUY
$446.73 - $548.2 $2.01 Million - $2.47 Million
4,504 New
4,504 $2.13 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Marietta Wealth Management, LLC Portfolio

Follow Marietta Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Wealth Management, LLC with notifications on news.